2024-01-30T15:14:05Z
2024-01-30T15:14:05Z
2022-05-10
2023-06-22T11:02:19Z
Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD), the optimal timing of complete revascularisation remains disputed. In this systematic review and meta-analysis our results suggest that outcomes are comparable for immediate and staged complete revascularisation in patients with ACS and MVD. However, evidence from randomised controlled trials remains scarce and cautious interpretation of these results is recommended. More non-biased evidence is necessary to aid future decision making on the optimal timing of complete revascularisation.
Article
Versió publicada
Anglès
Malalties coronàries; Derivació cardiopulmonar; Coronary diseases; Cardiopulmonary bypass
Springer Nature
Reproducció del document publicat a: https://doi.org/10.1007/s12471-022-01687-7
Netherlands Heart Journal, 2022, vol. 30, num. 10, p. 449-456
https://doi.org/10.1007/s12471-022-01687-7
cc by (c) Vriesendorp, Pieter A. et al., 2022
http://creativecommons.org/licenses/by/3.0/es/